Pharmacological interventions for apathy in Alzheimer's disease (Q24185815)

https://api.crossref.org/works/10.1002/14651858.CD012197

Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

21 January 2018

2 references

https://api.crossref.org/works/10.1002/14651858.CD012197

21 January 2018

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

The overlap between vascular disease and Alzheimer's disease--lessons from pathology

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

SSRI-induced apathy syndrome: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

The role of dopamine in reward and pleasure behaviour--review of data from preclinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Levodopa and bromocriptine in hypoxic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

A postmortem study of amino acid neurotransmitters in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Neuropathological correlates of behavioural disturbance in confirmed Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Nonpharmacologic management of behavioral symptoms in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

The role of norepinephrine in the behavioral and psychological symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Growth hormone response to clonidine predicts aggression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Assessment and management of behavioral and psychological symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Role of serotonin in the behavioral and psychological symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Behavioral correlates of GABAergic disruption in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

A SPECT study of apathy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Apathy in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

21 January 2018

Apathy is not depression

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

The global prevalence of dementia: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

A post-mortem study of the cholinergic and GABA systems in senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Neuroimaging correlates of apathy and depression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Depression and apathy in dementia: same syndrome or different constructs? A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

Transmission of a t(13q22q) chromosome observed in three generations with segregation of the translocation D1-trisomy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

Group differences in the relationship between apathy and depression.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

The GRADE approach and Bradford Hill's criteria for causation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

Apathy: a treatable syndrome

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

Modafinil therapy for apathy in an elderly patient

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

Apathy syndrome in Alzheimer's disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021

The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD012197

7 January 2021